Dubai is all set to host its first ever stem cell and regenerative medical centre.
It was recently announced that Emirates Hospital Jumeirah, an Emirates Healthcare company, has partnered with ReGen Medical Management Dubai to launch the said initiative.
This will make Emirates Hospital Jumeirah the first to receive approval from Dubai Health Authority and will be the first to offer a range of specialty regenerative services in the UAE region at ReGen At Emirates Hospital.
The opening follows more than 600 successful stem cell therapy treatments by ReGen Medical in the US.
ReGen at Emirates Hospital is certified for the medical tourism market and will operate under US Federal Drug Administration (FDA) standards, a statement said.
The staff will be led by ReGen Medical Management Dubai, founder, Dr Steven Victor, who has treated numerous patients for rejuvenation, anti-aging, joint problems and neurological conditions, including concussions, autism, dementia and Alzheimer’s.
Michael Davis, COO of NMC Healthcare, said: “We are pleased to partner with Dr Steven Victor and ReGen Medical. This partnership is a testament to our continued efforts to accelerate the healthcare landscape in the UAE and aligns with our vision to explore new territories and domains that will add value to the lives of our patients and broaden their treatment options.
“This new facility will provide innovative technologies to address a multitude of conditions and helps to reinforce our position as the largest private healthcare provider in The Middle East.”
Victor added: “We are proud to partner to offer the only dedicated stem cell and regenerative medical centre in the UAE, all while incorporating the latest advancements in cellular therapies to patients worldwide.”
Stromal vascular fraction cellular (SVFC) therapy, better known as stem cell therapy, is a rapidly expanding set of innovative medical technologies that restores cellular function by enabling the body to repair, replace and regenerate damaged, aging or diseased cells, tissues and organs.
The minimally invasive, proprietary procedure uses a patient’s own stem-cell-rich adipose or fat tissue to significantly boost success rates for patient outcomes in a wide variety of conditions including pain management, neurologic, orthopaedic and cardiovascular.
more recommended stories
UAE’s attorney general has ordered the arrest of an Asian Cup video posting social media
In the video, the suspects were.
Dubai’s Dubizzle classified website worth at $400m after completes acquisition of Nappers
UAE-based online classified website dubizzle is.
UAE-based electronics retail firm, Ecity plans to expand with Abu Dhabi Store
UAE-based electronics retail firm, Ecity, plans.
Dubai Healthcare Authority has announced a new license which allows international doctors to work in Dabai
The Dubai Healthcare City Authority has.